WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse models
Jason E. Conage‐Pough(Massachusetts Institute of Technology), Forest M. White(Center for Cancer Research), Jann N. Sarkaria(Mayo Clinic in Arizona), Nhan L. Tran(Translational Genomics Research Institute), Claire Sun(Hudson Institute of Medical Research), Ju‐Hee Oh(University of Minnesota), William F. Elmquist(University of Minnesota), Danielle M. Burgenske(Mayo Clinic in Arizona), Zhihua Mu, Brett L. Carlson(University of California, San Francisco), Nathalie Y.R. Agar(Texas Endosurgery Institute), Lily Liu, Gerard Baquer(Center for Pain and the Brain), Sylwia A. Stopka(Brigham and Women's Hospital), Paul A. Decker(University of California, San Francisco), Michael S. Regan(Brigham and Women's Hospital), Ann C. Mladek(Mayo Clinic), Jinqiang Zhang, Wei Zhong(Hegang People's Hospital), Katrina K. Bakken(Mayo Clinic in Arizona)
Cited by 5
Related Papers
Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae
|Nature Biotechnology|2002|1.6k
How many human proteoforms are there?
|Nature Chemical Biology|2018|945
Time-resolved Mass Spectrometry of Tyrosine Phosphorylation Sites in the Epidermal Growth Factor Receptor Signaling Network Reveals Dynamic Modules
|Molecular & Cellular Proteomics|2005|547
Rapid, Label-Free Detection of Brain Tumors with Stimulated Raman Scattering Microscopy
|Science Translational Medicine|2013|510